NCT07723326

Brief Summary

This randomized controlled trial aims to compare electrocautery and scalpel blade incisions during surgical extraction of impacted mandibular third molars. The study will evaluate postoperative pain, intraoperative blood loss, and wound healing in patients undergoing third molar surgery. A total of 78 participants will be randomly allocated in a 1:1 ratio to receive either a scalpel blade incision or an electrocautery incision under standardized surgical conditions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Aug 2026Dec 2026

First Submitted

Initial submission to the registry

July 20, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 23, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 20, 2026

Last Update Submit

July 20, 2026

Conditions

Keywords

electrocauteryscalpel bladeimpacted mandibular third molar

Outcome Measures

Primary Outcomes (1)

  • postoperative pain

    Postoperative pain at the surgical site will be assessed using a 0-10 Visual Analogue Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain

    24 hours, 48 hours, and 7 days after surgery.

Secondary Outcomes (2)

  • intraoperative blood loss

    During surgery (from first incision to final suture).

  • wound healing

    1 week and 4 weeks after surgery.

Study Arms (2)

scalpel blade incision group

EXPERIMENTAL

Participants will undergo surgical extraction of impacted mandibular third molars using a sterile No. 15 scalpel blade for the mucoperiosteal flap incision

Procedure: scalpel blade incision

electrocautery incision group

EXPERIMENTAL

Participants will undergo surgical extraction of impacted mandibular third molars using electrocautery in cutting mode for the mucoperiosteal flap incision

Procedure: electrocautery incision

Interventions

A fine electrocautery electrode in cutting mode at a standardized effective power setting will be used to make the mucoperiosteal flap incision during surgical extraction of the impacted mandibular third molar.

electrocautery incision group

A sterile No. 15 stainless-steel scalpel blade will be used to make the mucoperiosteal flap incision during surgical extraction of the impacted mandibular third molar.

scalpel blade incision group

Eligibility Criteria

Age15 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female patients.
  • Age 15 to 65 years.
  • Patients requiring surgical extraction of an impacted mandibular third molar. Patients classified as ASA I or ASA II.
  • Patients willing to provide written informed consent, or assent with parent/guardian permission where applicable, and attend scheduled follow-up visits

You may not qualify if:

  • \* Patients with uncontrolled systemic disease or immuno-compromised status.
  • Patients with bleeding disorders or those taking anticoagulant/antiplatelet drugs that cannot be safely withheld according to physician advice.
  • Patients with pacemaker or implanted electrical cardiac device.
  • Pregnant or lactating patients.
  • Patients with acute infection, pericoronitis, facial space infection, or pus discharge at the surgical site at the time of surgery.
  • Patients requiring bilateral third-molar extraction in the same sitting.
  • Patients unwilling to participate or unable to return for follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Islamic International Dental Hospital

Islamabad, 44000, Pakistan

Location

Study Officials

  • Uzair Luqman, BDS/FCPS

    department of ORAL AND MAXILLOFACIAL SURGERY ISLAMIC INTERNATIONAL DENTAL HOSPITAL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Muhammad Usama, BDS/FCPS

CONTACT

Uzair Luqman, BDS/FCPS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This is a single-blinded randomized controlled trial. The independent outcome assessor responsible for wound-healing and postoperative assessments will remain blinded to treatment allocation. The operating surgeon cannot be blinded because the incision techniques are visibly different.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective, two-arm, parallel-group, randomized controlled trial. Eligible patients requiring surgical extraction of an impacted mandibular third molar will be randomly allocated in a 1:1 ratio to either Arm A (scalpel blade incision) or Arm B (electrocautery incision) using a computer-generated randomization sequence. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes prepared by a person not involved in surgery or outcome assessment. All other surgical and perioperative conditions will be standardized between the two groups, and postoperative pain, intraoperative blood loss, and wound-healing outcomes will be compared.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2026

First Posted

July 23, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 23, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made publicly available

Locations